The Cracking Consciousness Study With Monroe & Neuphoria

You've explored the Monroe Focus levels. But, Bob Monroe said, "You might believe something, but you won't understand it until you can measure it with objective data." Now, for the first time, we can measure them. In partnership with Neuphoria, we're launching a groundbreaking EEG study to define Higher States of Consciousness. Join the World's First higher states of Consciousness Study.

Study Overview

• Status: Completed
• Conditions: Stress; Mental Energy
• Intervention / Treatment: Device: Neuphoria Wearable

Detailed Description

This remotely administered decentralized trial is designed to explore the potential of the Neuphoria device, a cutting-edge wearable neurofeedback headset, in enhancing cognitive performance and facilitating the attainment of peak mental states. By leveraging advanced EEG technology to monitor brainwave activity in real-time, this study aims to provide participants with personalized feedback, assisting them in training their brains to improve focus, creativity, and achieve flow states. The device serves as a comprehensive brain optimization platform, offering personalized assessments, data-driven insights, and actionable recommendations for mental well-being.

In an era where mindfulness and meditation are highly valued, yet often unquantified, this study emerges as a pioneering effort to measure these elusive higher states of consciousness scientifically. In collaboration with Neuphoria, this trial endeavors to blend the art of introspection with the precision of EEG technology, thereby transforming belief into understanding and folklore into facts. The ultimate goal is to redefine mental wellness by gaining a deeper understanding of consciousness shifts.

Participants in this trial are invited to embark on a unique journey of self-discovery, exploring their mental landscapes while capturing data that reflects their progress toward higher consciousness. Through engagement with meditation and mindfulness techniques, participants will not only gain insights into their stress levels and mindfulness tendencies, quantified through tools like the Perceived Stress Scale and the Freiburg Mindfulness Inventory, but also discover their personal pathways to enhanced mental wellness and consciousness.

The study's primary aim is to objectively measure shifts in participants' consciousness using EEG data, in conjunction with traditional mindfulness and stress metrics. By offering personalized insights into the effects of meditation and mindfulness on mental health, the study empowers participants to make informed decisions regarding their self-care practices.

The significance of this trial lies in its potential to transform subjective meditation experiences into objective, measurable data, thereby narrowing the gap between belief and measurable outcomes. Understanding the influence of mindfulness practices on consciousness could significantly advance mental health optimization strategies. While acknowledging the limitations in the universal applicability of its results, the personalized insights provided by this study promise to be invaluable for participants eager to deepen their mindfulness practice and achieve a state of equanimity. Through this innovative, remotely administered trial, we aim to illuminate the path to mental wellness and elevated consciousness for individuals across the globe.

• Study Type: Interventional
• Enrollment (Actual): 271
• Phase: Not Applicable

Contacts and Locations

Study Locations

• United States
  • New York
    • New York, New York, United States, 10003
      • Efforia

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: Adult; Older Adult
• Accepts Healthy Volunteers: Yes

Description

Inclusion Criteria:

• Can read and understand English.
• US resident.
• Willing and able to follow the requirements of the protocol.

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Health Services Research
• Allocation: N/A
• Interventional Model: Single Group Assignment
• Masking: None (Open Label)

Number of Arms

1

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
Experimental: Single Arm longitudinal where participants act as their own control	Device: Neuphoria Wearable; Neuphoria wearable measures Electroencephalography (EEG) brainwaves.

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Neuphoria Brain EEG	Neuphoria's wearable neurofeedback system harnesses real-time EEG to generate a rich, multidimensional cognitive profile by measuring five core metrics-mental state, mindset, nervous system activity, emotion, and breathing patterns-all displayed via its biohacking dashboard to offer users nuanced insights into their cognitive and physiological functioning	Change from baseline (Day 1-7) in cognitive and physiological profiles at 4 to 5 weeks (Day 23-37) after the start of the intervention
Perceived Stress Scale (Past Week Version)	The Perceived Stress Scale (Past Week Version) is a modified version of the classic stress assessment tool that evaluates stress levels based on recent experiences within the last week. This scale helps in understanding how various situations have recently affected an individual's feelings and perceived stress levels. By focusing on a shorter time frame, it provides a more immediate assessment of stress, which can be particularly useful for quickly evaluating the effectiveness of stress management strategies or interventions. The tool retains its original structure, ensuring its reliability while making it more relevant for current stress evaluation.	Change from baseline (Day 1-3) in perceived stress levels at 4 to 5 weeks (Day 27-33) after the start of the intervention
Freiburg Mindfulness Inventory	The Freiburg Mindfulness Inventory (FMI) is a valid and reliable questionnaire designed to measure mindfulness. The 14 items in the inventory cover all aspects of mindfulness. Participants are asked to reflect on their experiences over a certain period of time and answer each statement as honestly and spontaneously as possible. There are no 'right' or 'wrong' answers, the focus is solely on personal experience.	Change from baseline (Day 1-3) in mindfulness levels at 4 to 5 weeks (Day 27-33) after the start of the intervention

Collaborators and Investigators

• Sponsor: Efforia, Inc

Publications and helpful links

Helpful Links

• Additional information and join instructions on Efforia

Study record dates

Study Major Dates

• Study Start (Actual): August 10, 2025
• Primary Completion (Actual): January 10, 2026
• Study Completion (Actual): January 10, 2026

Study Registration Dates

• First Submitted: November 20, 2025
• First Submitted That Met QC Criteria: November 20, 2025
• First Posted (Actual): December 1, 2025

Study Record Updates

• Last Update Posted (Actual): May 28, 2026
• Last Update Submitted That Met QC Criteria: May 26, 2026
• Last Verified: May 1, 2026

More Information

Terms related to this study

• Other Study ID Numbers: 41035

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: Yes
• product manufactured in and exported from the U.S.: No